Public Health officials awaiting evidence on AstraZeneca blood clot concerns

Chair of the National Immunisation Advisory Committee, Professor Karina Butler. Picture: Colin Keegan, Collins Dublin

Chair of the National Immunisation Advisory Committee, Professor Karina Butler. Picture: Colin Keegan, Collins Dublin

Use of the AstraZeneca Covid-19 vaccine here will only resume once public health officials are satisfied that the blood-clotting issues surrounding it are coincidental.

Speaking at this evening’s public health briefing, Chair of the National Immunisation Advisory Committee, Professor Karina Butler said that all vaccines authorised for use in Ireland were "proven to be very effective against severe Covid-19 disease."

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited